Tidal Investments LLC Buys 4,939 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Tidal Investments LLC raised its stake in Henry Schein, Inc. (NASDAQ:HSIC) by 54.9% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 13,942 shares of the company’s stock after purchasing an additional 4,939 shares during the quarter. Tidal Investments LLC’s holdings in Henry Schein were worth $1,016,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in the stock. Cromwell Holdings LLC boosted its holdings in shares of Henry Schein by 93.4% in the 3rd quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock valued at $26,000 after buying an additional 170 shares during the last quarter. Studio Investment Management LLC lifted its stake in Henry Schein by 3.8% in the third quarter. Studio Investment Management LLC now owns 4,674 shares of the company’s stock valued at $341,000 after acquiring an additional 172 shares during the last quarter. Simplify Asset Management Inc. grew its position in shares of Henry Schein by 5.0% in the 2nd quarter. Simplify Asset Management Inc. now owns 3,695 shares of the company’s stock valued at $237,000 after acquiring an additional 175 shares during the period. Huntington National Bank increased its stake in shares of Henry Schein by 16.8% during the 3rd quarter. Huntington National Bank now owns 1,515 shares of the company’s stock worth $110,000 after purchasing an additional 218 shares during the last quarter. Finally, Tempus Wealth Planning LLC raised its holdings in shares of Henry Schein by 6.0% in the 2nd quarter. Tempus Wealth Planning LLC now owns 4,607 shares of the company’s stock valued at $295,000 after purchasing an additional 260 shares during the period. Institutional investors and hedge funds own 96.62% of the company’s stock.

Henry Schein Stock Down 2.4 %

NASDAQ HSIC opened at $68.95 on Friday. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. The company has a market cap of $8.60 billion, a price-to-earnings ratio of 28.37, a PEG ratio of 2.31 and a beta of 0.87. The company has a 50 day moving average of $72.43 and a 200-day moving average of $70.13. Henry Schein, Inc. has a 1-year low of $63.67 and a 1-year high of $82.63.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Tuesday, November 5th. The company reported $1.22 earnings per share for the quarter, beating the consensus estimate of $1.17 by $0.05. The firm had revenue of $3.17 billion during the quarter, compared to analysts’ expectations of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The company’s quarterly revenue was up .4% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.32 EPS. On average, equities research analysts expect that Henry Schein, Inc. will post 4.78 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, COO Michael S. Ettinger sold 12,240 shares of the company’s stock in a transaction that occurred on Monday, November 18th. The shares were sold at an average price of $75.00, for a total transaction of $918,000.00. Following the completion of the sale, the chief operating officer now owns 87,706 shares of the company’s stock, valued at approximately $6,577,950. This represents a 12.25 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 1.14% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have issued reports on HSIC shares. StockNews.com upgraded Henry Schein from a “sell” rating to a “hold” rating in a research note on Thursday, November 7th. Barrington Research reaffirmed an “outperform” rating and set a $82.00 price target on shares of Henry Schein in a report on Wednesday, November 6th. Mizuho started coverage on shares of Henry Schein in a report on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 price objective on the stock. Finally, Evercore ISI increased their price objective on shares of Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a research report on Tuesday, October 8th. Seven investment analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, Henry Schein currently has an average rating of “Moderate Buy” and an average price target of $78.89.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.